<!DOCTYPE html>
<html>
    <head>
        <title>STD Tx Guidelines</title>
    </head>
    <body>
        <!-- Start of page -->
        <div data-role="page" id="g345" data-theme="a">
            <div data-role="header" data-id="guidelines-header" data-theme="b" data-position="fixed">
                <a href="lv-345.html" class="ui-btn ui-icon-back ui-btn-icon-notext ui-corner-all" aria-label="back"></a>
                <h3>STD Tx Guidelines</h3>
                <a href="#nav-panel" class="ui-btn ui-icon-bars ui-btn-icon-notext ui-corner-all" aria-label="main menu"></a>
            </div>
            <div data-role="content">
            <div id=guidelines_breadcrumbs>
            
                    <a href="lv-341.html" >Full Guidelines</a><span class="carrot"> > </span>
                    <a href="lv-342.html" >Vaccine-Preventable STDs</a><span class="carrot"> > </span>
                    <a href="lv-345.html" >Hepatitis A</a><span class="carrot"> > </span>
                    <a href="lv-345.html" >Prevention</a><span class="carrot"> > </span>Overview
            </div>
            </br><h3 class="sgc-1" id="sigil_toc_id_345">
 Prevention
</h3>
<p>
 Two products are available for the prevention of HAV infection:&nbsp;hepatitis A vaccine (Table 2) and immune globulin (IG) for IM administration. Hepatitis A vaccines are prepared from formalin-inactivated, cell-culture&ndash;derived HAV and have been available in the United States since 1995, initially for persons aged &ge;2 years. In 2005, the vaccines were approved by FDA for persons aged &ge;12 months, and the vaccine is available for eligible children and adolescents aged &lt;19 years through the VFC program (telephone: 800-232-4636).
</p>
<p>
    <div id="boxheadwrap">
        TABLE 2. Recommended regimens: dose and schedule for hepatitis A vaccines
    </div>

    <div id="table2wrap">
        <table>
            <tr class="trheader">
                <th style="text-align:left;">Vaccine</th>

                <th>Age (yrs)</th>

                <th>Dose</th>

                <th>Volume (mL)</th>

                <th>Two-dose schedule (months)*</th>
            </tr>

            <tr>
                <td style="padding-bottom: 1em;  padding-right: .5em;">HAVRIX<sup>†</sup></td>

                <td>1–18</td>

                <td>720 (EL.U.)</td>

                <td>0.5</td>

                <td>0 (6–12)</td>
            </tr>

            <tr>
                <td>&nbsp;</td>

                <td>&nbsp;&gt;18</td>

                <td>1,440 (EL.U.)</td>

                <td>1.0</td>

                <td>0 (6–12)</td>
            </tr>

            <tr class="trspace">
                <td style="padding-bottom: 1em; padding-right: .5em;">VAQTA<sup>§</sup></td>

                <td>1–18</td>

                <td>25 (U)</td>

                <td>0.5</td>

                <td>0 (6–18)</td>
            </tr>

            <tr class="trbottomline">
                <td>&nbsp;</td>

                <td>&nbsp;&gt;18</td>

                <td>50 (U)</td>

                <td>1.0</td>

                <td>0 (6–18)</td>
            </tr>
        </table>

        <div id="bottom_table_text_wrap">
            <strong>Source:</strong> CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(No. RR-7).

            <div id="box_section_spacer"></div><strong>Abbreviations:</strong> EL.U = Enzyme-linked immunosorbent assay (ELISA) units; U = units.

            <div id="box_section_spacer"></div>

            <div id="hangingindent">
                * 0 months represents timing of the initial dose; subsequent numbers represent months after the initial dose.
            </div>

            <div id="hangingindent">
                <sup>†</sup> Hepatitis A vaccine, inactivated, GlaxoSmithKline Biologicals; this vaccine is also licensed for a 3-dose series in children aged 2–18 years, with 360 EL.U, 0.5 mL doses at 0, 1, and 6–12 months.
            </div>

            <div id="hangingindent">
                <sup>§</sup> Hepatitis A vaccine, inactivated, Merck & Co., Inc.
            </div>
        </div>
    </div>

            </div>
        <div data-role="panel" data-display="push" data-theme="b" id="nav-panel">
            <ul data-role="listview">
                <li data-icon="delete"><a href="#" data-rel="close">Close menu</a></li>
                <li><a href="../conditions/c0-clv.html">Condition Quick Pick</a></li>
                <li><a href="../guidelines/lv-0.html">Full STD Tx Guidelines</a></li>
                <li><a href="../page/hx-pdf.html">Taking a Sexual Hx PDF</a></li>
                <li><a href="../terms/1.html">Terms and Abbreviations</a></li>
                <li><a href="../refs/lv-0.html">References</a></li>
                <li><a href="../page/about_us.html">About Us</a></li>
            </ul>
        </div><!-- /panel -->
    
        </div>
        <!-- end of guidelines heading page -->
    </body>
</html>
    